Timing & pharmacokinetics
How long does NMN take to work?
Onset timing for NMN varies in the clinical literature. Onset timing is not well-quantified in our dataset — refer to clinical citations on the main entry.
Onset
—
Half-life
—
Duration
—
Timing
AM
Key facts
- typical dose
- 250–1000 mg
- dose frequency
- 1 dose
- timing
- AM
- with food
- optional
- safety score
- 5/5
- evidence grade
- B
- class
- neuroprotective
- PubMed citations
- 600
- legal status (US)
- Over-the-counter
- legal status (UK)
- Over-the-counter
- legal status (EU)
- Over-the-counter
- legal status (AU)
- Over-the-counter
- primary mechanism
- Direct precursor to NAD+ — one biosynthetic step closer than nicotinamide riboside, bypassing the NRK1/NRK2 enzymatic step.
Onset window
NMN onset times in the published literature vary widely. Refer to the citations on the main NMN entry for compound-specific pharmacokinetic data.
Food effect: Food has only modest effect on NMN onset. Take with or without food depending on GI tolerance.
Half-life and dosing frequency
Half-life is not characterised in our dataset.
Acute vs. chronic effect
Some nootropics work the first time you take them (NMN may or may not). Others — adaptogens, racetams, and most botanicals targeting BDNF or NGF pathways — require 2–4 weeks of daily dosing before the full effect emerges.
If you don’t feel anything after a single dose and the compound is in the chronic-effect category, that is normal — extend the trial to 2–4 weeks before evaluating. If it is in the acute category and you feel nothing, consider dose, vendor sourcing, or whether the compound matches your goal.
Protocol note from the NMN entry
Sublingual debated vs encapsulated.
Mechanism, safety, and citations for NMN are on the main reference page — see NMN. For full dose protocol see NMN dosage. To check for stack-level pharmacokinetic conflicts, use the interaction checker.
Onset and pharmacokinetic data reflect the published literature for healthy adults at typical doses. Individual variation in absorption, metabolism (CYP genotype), and gut transit can shift onset by ±50%. This page is informational and not medical advice. See our full disclaimer.